Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 22:09:03 - browse：942

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Study: AI not yet building 'n

focus

WSS

RaDonda Vaught links Vanderbilt hospital issues to patient death

Sanofi strikes deal with Novavax, boosting the vaccine maker

Making AI in medicine accessible to smaller, and rural hospitals

Why depression after traumatic brain injury is distinct

Ebola: Gilead Sciences antiviral shows promise as new treatment

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

hotspot

Wikipedia

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

H5N1 bird flu: what we're starting to learn about infection in cows

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study: AI not yet building 'n

Trump demands the U.S. pay no more for drugs than other countries … again

Elevance, private equity launch primary care company

How one medical school became remarkably diverse

Medicare coverage of Wegovy, once blocked, now looks possible

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Amid AI frenzy, a top HHS official's quest to create safeguards

entertainment

EPA limits use of carcinogenic gas for sterilizing medical devices

Readout LOUD podcast: What to know about H5N1 bird flu

Study: People of West African ancestry at greater risk of cardiac amyloidosis

What nurses really want: sufficient staffing for patient care

Pushing for an NIH office for post

Software glitch causes Tandem insulin pump to shutdown, FDA warns

explore

hotspot

focus

knowledge